Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Ceremonial Behavior | 1 | 2019 | 63 | 0.72 | Why? |
| Patient Care Bundles | 1 | 2019 | 137 | 0.65 | Why? |
| Arabs | 1 | 2019 | 298 | 0.60 | Why? |
| Islam | 1 | 2019 | 545 | 0.47 | Why? |
| Cardiology Service, Hospital | 1 | 2019 | 602 | 0.46 | Why? |
| Antibodies, Monoclonal, Humanized | 3 | 2021 | 9335 | 0.42 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 1510 | 0.38 | Why? |
| Critical Pathways | 1 | 2019 | 1587 | 0.36 | Why? |
| Delivery of Health Care, Integrated | 1 | 2019 | 1549 | 0.33 | Why? |
| Observational Studies as Topic | 3 | 2020 | 1887 | 0.27 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.25 | Why? |
| Immunosuppressive Agents | 1 | 2021 | 6331 | 0.24 | Why? |
| Hydroxychloroquine | 3 | 2021 | 12447 | 0.24 | Why? |
| Hypertension | 2 | 2020 | 8895 | 0.22 | Why? |
| Heart Diseases | 1 | 2019 | 3503 | 0.22 | Why? |
| Odds Ratio | 2 | 2021 | 5861 | 0.19 | Why? |
| Elasticity | 1 | 2018 | 70 | 0.19 | Why? |
| Spinal Cord Compression | 1 | 2018 | 35 | 0.19 | Why? |
| Placebos | 1 | 2021 | 629 | 0.18 | Why? |
| Hepatocytes | 1 | 2020 | 549 | 0.16 | Why? |
| Spinal Cord | 1 | 2018 | 281 | 0.16 | Why? |
| Bradycardia | 1 | 2020 | 292 | 0.16 | Why? |
| Elasticity Imaging Techniques | 1 | 2018 | 194 | 0.16 | Why? |
| Randomized Controlled Trials as Topic | 5 | 2021 | 10649 | 0.15 | Why? |
| Mineralocorticoid Receptor Antagonists | 1 | 2017 | 203 | 0.14 | Why? |
| Death, Sudden, Cardiac | 1 | 2020 | 522 | 0.14 | Why? |
| Serine Endopeptidases | 2 | 2020 | 4606 | 0.14 | Why? |
| Standard of Care | 1 | 2021 | 1297 | 0.13 | Why? |
| Cardiomyopathy, Dilated | 1 | 2017 | 251 | 0.13 | Why? |
| Transportation of Patients | 1 | 2019 | 494 | 0.13 | Why? |
| Saudi Arabia | 3 | 2019 | 4423 | 0.13 | Why? |
| Drug Interactions | 1 | 2020 | 1653 | 0.12 | Why? |
| Heart Failure | 3 | 2020 | 6638 | 0.12 | Why? |
| Safety | 1 | 2020 | 1583 | 0.12 | Why? |
| Receptors, Interleukin-6 | 1 | 2020 | 1383 | 0.12 | Why? |
| Circadian Rhythm | 1 | 2018 | 607 | 0.12 | Why? |
| Acute Lung Injury | 1 | 2021 | 904 | 0.12 | Why? |
| Cardiovascular Agents | 1 | 2018 | 663 | 0.12 | Why? |
| Cardiac Catheterization | 1 | 2019 | 882 | 0.11 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2020 | 5277 | 0.11 | Why? |
| Heart | 1 | 2020 | 1791 | 0.10 | Why? |
| Program Evaluation | 1 | 2019 | 1929 | 0.10 | Why? |
| Feasibility Studies | 1 | 2019 | 3467 | 0.09 | Why? |
| Azithromycin | 2 | 2021 | 3943 | 0.09 | Why? |
| Risk | 1 | 2020 | 5288 | 0.09 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.09 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.08 | Why? |
| Interferon Type I | 1 | 2020 | 2789 | 0.08 | Why? |
| New York City | 1 | 2021 | 7432 | 0.08 | Why? |
| Thrombolytic Therapy | 1 | 2018 | 2218 | 0.08 | Why? |
| Arrhythmias, Cardiac | 1 | 2020 | 2510 | 0.08 | Why? |
| Kidney | 1 | 2020 | 3648 | 0.08 | Why? |
| Chloroquine | 1 | 2021 | 3152 | 0.07 | Why? |
| Respiration, Artificial | 2 | 2021 | 22116 | 0.07 | Why? |
| Cardiac Surgical Procedures | 1 | 2019 | 1931 | 0.07 | Why? |
| Humans | 16 | 2021 | 930598 | 0.07 | Why? |
| Patient Care Team | 1 | 2019 | 3556 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.07 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.06 | Why? |
| Rats | 2 | 2020 | 2764 | 0.06 | Why? |
| Atrial Fibrillation | 1 | 2017 | 2320 | 0.06 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2018 | 3051 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2021 | 6153 | 0.06 | Why? |
| Percutaneous Coronary Intervention | 1 | 2018 | 3646 | 0.06 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.06 | Why? |
| Time-to-Treatment | 1 | 2018 | 5883 | 0.06 | Why? |
| Griseofulvin | 1 | 2020 | 14 | 0.06 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.05 | Why? |
| Mice | 1 | 2020 | 21357 | 0.05 | Why? |
| Arthralgia | 1 | 2021 | 173 | 0.05 | Why? |
| Laminectomy | 1 | 2018 | 27 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Hospitalization | 5 | 2021 | 54280 | 0.05 | Why? |
| Animals | 4 | 2020 | 78931 | 0.05 | Why? |
| Time Factors | 2 | 2019 | 31397 | 0.05 | Why? |
| Acetaminophen | 1 | 2020 | 326 | 0.04 | Why? |
| Models, Animal | 1 | 2018 | 788 | 0.04 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.03 | Why? |
| Autoimmunity | 1 | 2021 | 841 | 0.03 | Why? |
| Middle East | 1 | 2018 | 1418 | 0.03 | Why? |
| Adrenergic beta-Antagonists | 1 | 2017 | 465 | 0.03 | Why? |
| Registries | 3 | 2018 | 12327 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| Dogs | 1 | 2018 | 2529 | 0.03 | Why? |
| Fatigue | 1 | 2021 | 2479 | 0.03 | Why? |
| Natriuretic Peptide, Brain | 1 | 2017 | 1215 | 0.02 | Why? |
| Cells, Cultured | 1 | 2020 | 5835 | 0.02 | Why? |
| Ventricular Dysfunction, Left | 1 | 2017 | 993 | 0.02 | Why? |
| Gastrointestinal Microbiome | 1 | 2021 | 1961 | 0.02 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.02 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2020 | 4020 | 0.02 | Why? |
| Hypoglycemic Agents | 1 | 2020 | 2165 | 0.02 | Why? |
| Peptide Fragments | 1 | 2017 | 2075 | 0.02 | Why? |
| Liver | 1 | 2020 | 4007 | 0.02 | Why? |
| Renin-Angiotensin System | 1 | 2021 | 3661 | 0.02 | Why? |
| Immunocompromised Host | 1 | 2021 | 5150 | 0.02 | Why? |
| Symptom Assessment | 1 | 2017 | 4967 | 0.02 | Why? |
| Coronary Artery Disease | 1 | 2017 | 2570 | 0.01 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Mortality | 1 | 2017 | 7132 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Depression | 1 | 2021 | 14116 | 0.01 | Why? |
| Aged | 3 | 2018 | 215776 | 0.01 | Why? |
| Anxiety | 1 | 2021 | 17311 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Middle Aged | 3 | 2018 | 270681 | 0.01 | Why? |
| Stroke | 1 | 2017 | 8839 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Male | 3 | 2018 | 367725 | 0.01 | Why? |
| Female | 3 | 2018 | 380317 | 0.01 | Why? |
| Adult | 2 | 2018 | 244371 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.00 | Why? |
Kashour's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(120)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(61)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_